Sildenafil to Facilitate Weaning From Inhaled Nitric Oxide and Mechanical Ventilation in a Patient With Severe Secondary Pulmonary Hypertension and a Patent Foramen Ovale

References

1. 1.↵
   1. Litinsky I,
   2. Elkayam O,
   3. Flusser G,
   4. Segal R,
   5. Yaron M,
   6. Caspi D

   . Sarcoidosis: TB or not TB? Ann Rheum Dis 2002;61(5):385–386.

   OpenUrlFREE Full Text
2. 2.↵
   1. Gupta D,
   2. Agarwal R,
   3. Aggarwal AN,
   4. Jindal SK

   . Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 2007;30(3):508–516.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Shachor Y,
   2. Schindler D,
   3. Siegal A,
   4. Lieberman D,
   5. Mikulski Y,
   6. Bruderman I

   . Increased incidence of pulmonary tuberculosis in chronic interstitial lung disease. Thorax 1989;44(2):151–153.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Handa T,
   2. Nagai S,
   3. Miki S,
   4. Fushimi Y,
   5. Ohta K,
   6. Mishima M,
   7. et al

   . Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006;129(5):1246–1252.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Preston IR,
   2. Klinger JR,
   3. Landzberg MJ,
   4. Houtchens J,
   5. Nelson D,
   6. Hill NS

   . Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension. Chest 2001;120(3):866–872.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Milman N,
   2. Burton CM,
   3. Iversen M,
   4. Videbaek R,
   5. Jensen CV,
   6. Carlsen J

   . Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil? J Heart Lung Transplant 2008;27(3):329–334.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Mar'iandyshev AO

   . [Causes and mechanisms of the development of chronic cor pulmonale in patients with tuberculosis and chronic nonspecific diseases of the lungs]. Probl Tuberk 1991;(4):70–73. Article in Russian.
8. 8.↵
   1. Kurzyna M,
   2. Dabrowski M,
   3. Bielecki D,
   4. Fijalkowska A,
   5. Pruszczyk P,
   6. Opolski G,
   7. et al

   . Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest 2007;131(4):977–983.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Rozkovec A,
   2. Montanes P,
   3. Oakley CM

   . Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 1986;55(5):449–458.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Nootens MT,
    2. Berarducci LA,
    3. Kaufmann E,
    4. Devries S,
    5. Rich S

    . The prevalence and significance of a patent foramen ovale in pulmonary hypertension. Chest 1993;104(6):1673–1675.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Wensel R,
    2. Opitz CF,
    3. Anker SD,
    4. Winkler J,
    5. Hoffken G,
    6. Kleber FX,
    7. et al

    . Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002;106(3):319–324.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Trachte AL,
    2. Lobato EB,
    3. Urdaneta F,
    4. Hess PJ,
    5. Klodell CT,
    6. Martin TD,
    7. et al

    . Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg 2005;79(1):194–197.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Ng J,
    2. Finney SJ,
    3. Shulman R,
    4. Bellingan GJ,
    5. Singer M,
    6. Glynne PA

    . Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil? Br J Anaesth 2005;94(6):774–777.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Stanopoulos I,
    2. Manolakoglou N,
    3. Pitsiou G,
    4. Trigonis I,
    5. Tsiata EA,
    6. Boutou AK,
    7. et al

    . Sildenafil may facilitate weaning in mechanically ventilated COPD patients: a report of three cases. Anaesth Intensive Care 2007;35(4):610–613.

    OpenUrlPubMed
15. 15.↵
    1. Karakaya O,
    2. Ozdemir N,
    3. Kaymaz C,
    4. Barutcu I

    . Dramatic decrease in the pulmonary artery systolic pressure and disappearance of the interatrial shunt with sildenafil treatment in a patient with primary pulmonary hypertension with atrial septal aneurysm and a severe right to left shunt through the patent foramen ovale. Int J Cardiol 2006;110(1):97–99.

    OpenUrlPubMed
16. 16.↵
    1. Pitsiou GG,
    2. Chavouzis N,
    3. Nakou C,
    4. Boutou AK,
    5. Argyropoulou P,
    6. Stanopoulos I

    . Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy? J Heart Lung Transplant 2009;28(6):651–653.

    OpenUrlCrossRefPubMed